Vimarsana
Biggest News Aggregation in the World

Page 8 - Director Simon News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Director Simon. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Director Simon Today - Breaking & Trending Today

StockNews.com Begins Coverage on Xenon Pharmaceuticals (NASDAQ:XENE) - Vimarsana News

StockNews.com Begins Coverage on Xenon Pharmaceuticals (NASDAQ:XENE)

StockNews.com assumed coverage on shares of Xenon Pharmaceuticals (NASDAQ:XENE – Free Report) in a research report report published on Thursday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Several other analysts have also commented on XENE. Cantor Fitzgerald assumed coverage on shares of Xenon Pharmaceuticals in a report on Tuesday, April […]

Xenon Pharmaceuticals (NASDAQ:XENE) Research Coverage Started at StockNews.com - Vimarsana News

Xenon Pharmaceuticals (NASDAQ:XENE) Research Coverage Started at StockNews.com

StockNews.com began coverage on shares of Xenon Pharmaceuticals (NASDAQ:XENE – Free Report) in a research note issued to investors on Thursday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. A number of other brokerages have also recently issued reports on XENE. Wedbush reiterated an outperform rating and set a $47.00 price objective […]

Source: wkrb13.com
Moran Wealth Management LLC Purchases Shares of 67,613 Xenon Pharmaceuticals Inc. (NASDAQ:XENE) - Vimarsana News

Moran Wealth Management LLC Purchases Shares of 67,613 Xenon Pharmaceuticals Inc. (NASDAQ:XENE)

Moran Wealth Management LLC purchased a new stake in Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Free Report) in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 67,613 shares of the biopharmaceutical company’s stock, valued at approximately $2,420,000. Moran Wealth Management LLC owned about 0.11% of Xenon […]

Source: wkrb13.com
Victory Capital Management Inc. Takes Position in Xenon Pharmaceuticals Inc. (NASDAQ:XENE) - Vimarsana News

Victory Capital Management Inc. Takes Position in Xenon Pharmaceuticals Inc. (NASDAQ:XENE)

Victory Capital Management Inc. acquired a new stake in Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Free Report) during the 1st quarter, according to its most recent filing with the SEC. The institutional investor acquired 28,190 shares of the biopharmaceutical company’s stock, valued at approximately $1,009,000. Several other large investors also recently modified their holdings of XENE. […]

Research Analysts Offer Predictions for Xenon Pharmaceuticals Inc.'s FY2024 Earnings (NASDAQ:XENE) - Vimarsana News

Research Analysts Offer Predictions for Xenon Pharmaceuticals Inc.'s FY2024 Earnings (NASDAQ:XENE)

Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Free Report) – Equities research analysts at Cantor Fitzgerald issued their FY2024 EPS estimates for Xenon Pharmaceuticals in a research note issued on Tuesday, July 11th. Cantor Fitzgerald analyst C. Duncan expects that the biopharmaceutical company will post earnings per share of ($2.42) for the year. Cantor Fitzgerald currently has […]